Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...

Title: Biparatopic anti-HER2 antibody drug conjugate (ADC) JSKN003 in the treatment of primary platinum-refractory ovarian cancer (OC) Presentation Number: 1079P Onsite Poster display date: Saturday, ...

(“CSPC”) (Stock Code: 1093.HK) jointly announced that biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted another breakthrough therapy designation by the Center for Drug ...

You can practice using the Google Certified Database Engineer Exam Simulator and measure your progress with the GCP Certified Professional DevOps Engineer Practice Test.

“DESTINY-Breast11 results support T-DXd [plus] THP as a more effective and less toxic neoadjuvant treatment compared with ddAC-THP, and it may become the preferred regimen for patients with high-risk, ...

Like an abusive partner, the federal government is isolating domestic violence survivors by making help-seeking scarier and riskier.

On Oct. 6, more than 51,000 teachers across Alberta walked off the job after months of failed negotiations between the ...

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

AstraZeneca and Daiichi Sankyo’s star drug Enhertu has delivered a double knockout, showing its ability to stave off early breast cancer in two pivotal clinical trials. | AstraZeneca and Daiichi ...

Emphasizing school choice, the Clark County School District (CCSD) announced Friday that applications are open for magnet ...

Microsoft, OpenAI and Anthropic are providing millions of dollars for AI training to the American Federation of Teachers, the ...

Marblehead School Committee approves policy revisions, adopts domestic violence awareness proclamation, and discusses lights ...